Investor
Monograph Capital
London · United Kingdom · Founded 2021
Stage
Seed–Series B
Sectors
2 sectors
Cheque
Not confirmed
Invests in
Not confirmed
Sectors
B2B SaaSDigital Health
About
A transatlantic team focuses on sourcing scientific innovation and supporting company development across boundaries. They partner with young companies and entrepreneurs to support breakthrough therapeutics and diagnostics. The team combines medical expertise and operating experience to help create value for company partners.
Portfolio · 5 · tap a company to read about it
Recent deals
- 2026-06Ollin BiosciencesSeries B
- 2025-03Elevara MedicinesSeries A
- 2025-02Maxion TherapeuticsSeries A
- 2024-12Ouro MedicinesSeries A
- 2024-02Nocion TherapeuticsSeries BLed
- 2023-12SudoSeries B
- 2023-04ODAIASeries BLed
- 2022-12RegASKSeries ALed
- 2022-06MiroBioSeries B
- 2021-11AviadoBioSeries ALed
- 2021-08Human Immunology BiosciencesSeries ALed